Clinical Trial Update: Insulin Glargine in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Sanofi-sponsored Phase 4 trial evaluating insulin glargine in Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED